High‐flow nasal cannula oxygen therapy for the treatment of acute respiratory failure secondary to SARS‐CoV‐2 pneumonia out of ICU

High‐flow nasal cannula oxygen therapy for the treatment of acute respiratory failure secondary to SARS‐CoV‐2 pneumonia out of ICU

Abstract Introduction and objectives High‐flow nasal cannula oxygen therapy (HFNC) has been successfully used for the treatment of acute hypoxaemic respiratory failure (AHRF) secondary to SARS‐CoV‐2 pneumonia and being effective in reducing progression to invasive mechanical ventilation. The objecti...

Full description

Bibliographic Details
Main Authors: Sonia Castro, Sandra Pedrero, Luis Alberto Ruiz, Leyre Serrano, Rafael Zalacain, Silvia Pérez‐Fernández, Milagros Iriberri, Valentín Cabriada
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:The Clinical Respiratory Journal
Subjects:
COVID‐19
non‐invasive ventilation
oxygen inhalation therapy
respiratory insufficiency
respiratory therapy
Online Access:https://doi.org/10.1111/crj.13679

Internet

https://doi.org/10.1111/crj.13679

Similar Items